TOBI® PODHALER®
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Mylan Inc.
Overview
TOBI® PODHALER® is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
TOBI® PODHALER® clinical trials
Explore related
Medical disclaimer. This page summarizes research about TOBI® PODHALER® for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.